← Back to Search

Ultrasound-CT Fusion Guidance for CT Guided Pelvic Injection

N/A
Waitlist Available
Led By Brian Holly, MD
Research Sponsored by Clear Guide Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following intervention (within 2 hours)
Awards & highlights

Study Summary

The objective of this research is to use the Clear Guide SCENERGY technology, an FDA approved Ultrasound-CT fusion imaging system, that allows the user to fuse CT images onto a real-time ultrasound that is being performed on the patient. This fusion system will be used to perform ultrasound guided needle placements for patients undergoing percutaneous CT guided needle-based intervention. This study will consist of 20 patients, 10 patients using the CGM SCENERGY US-CT system and 10 patients using guidance only. The primary goal of the study is to prove that the new imaging fusion system is comparable to using either CT or US guidance alone to guide needle placement.

Eligible Conditions
  • CT Biopsy
  • CT Guided Pelvic Injection
  • CT Guided Drain Placement

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following intervention (within 2 hours)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following intervention (within 2 hours) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of CT scans or CT fluoroscopic images
Secondary outcome measures
Success of needle placement
Time to target
Total procedure time

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ultrasound-CT Fusion GuidanceExperimental Treatment1 Intervention
The participants in this group (test group) will utilize the ultrasound-CT fusion system for guiding needle placement.
Group II: CT GuidanceActive Control1 Intervention
The participants in this group (control group) will receive the procedure with traditional CT methods and equipment, for guiding needle placement.

Find a Location

Who is running the clinical trial?

Clear Guide MedicalLead Sponsor
8 Previous Clinical Trials
159 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,262 Previous Clinical Trials
14,823,144 Total Patients Enrolled
Brian Holly, MDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025